Texas MDL Panel Consolidates Mylan Cases
The Texas multidistrict litigation panel has consolidated cases alleging that Mylan Pharmaceutical Inc. failed to warn people that its anti-seizure medication causes the development of severe skin disorders....To view the full article, register now.
Already a subscriber? Click here to view full article